LifeMD Inc (LFMD) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
LifeMD Inc stock (LFMD) is currently trading at $3.90. LifeMD Inc PS ratio (Price-to-Sales) is 0.99. Analyst consensus price target for LFMD is $9.88. WallStSmart rates LFMD as Sell.
- LFMD PE ratio analysis and historical PE chart
- LFMD PS ratio (Price-to-Sales) history and trend
- LFMD intrinsic value — DCF, Graham Number, EPV models
- LFMD stock price prediction 2025 2026 2027 2028 2029 2030
- LFMD fair value vs current price
- LFMD insider transactions and insider buying
- Is LFMD undervalued or overvalued?
- LifeMD Inc financial analysis — revenue, earnings, cash flow
- LFMD Piotroski F-Score and Altman Z-Score
- LFMD analyst price target and Smart Rating
LifeMD Inc
📊 No data available
Try selecting a different time range
Smart Analysis
LifeMD Inc (LFMD) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
LifeMD Inc (LFMD) Key Strengths (1)
Paying less than $1 for every $1 of annual revenue
Supporting Valuation Data
LifeMD Inc (LFMD) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Revenue declining -27.10%, a shrinking business
Very expensive at 8.1x book value
Micro-cap company with very limited liquidity and high volatility
Thin profit margins with limited profitability
Moderate institutional interest at 39.74%
LifeMD Inc (LFMD) Detailed Analysis Report
Overall Assessment
This company scores 26/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 1 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 2.1/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales. Valuation metrics including Price/Sales (0.99) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Book (8.08) suggest expensive pricing. Growth concerns include Revenue Growth at -27.10%, which may limit upside. Profitability pressure is visible in Return on Equity at -131.20%, Operating Margin at -2.34%, Profit Margin at 7.40%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -131.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -27.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
LFMD Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
LFMD's Price-to-Sales ratio of 0.99x trades at a 22% premium to its historical average of 0.81x (43th percentile). The current valuation is 2% below its historical high of 1.01x set in Mar 2026, and 94% above its historical low of 0.51x in Mar 2026. Over the past 12 months, the PS ratio has expanded from ~0.5x, reflecting growing market expectations outpacing revenue growth.
Compare LFMD with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for LifeMD Inc (LFMD) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
LifeMD Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 194M with 27% decline year-over-year. Profit margins are thin at 7.4%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Revenue contracted 27% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -3M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Margin expansion: can LifeMD Inc push profit margins above 15% as the business scales?
Volatility is elevated with a beta of 2.01, so expect amplified moves relative to the broader market.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact LifeMD Inc.
Bottom Line
LifeMD Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About LifeMD Inc(LFMD)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
LifeMD, Inc. is a direct-to-patient telehealth company connecting consumers with healthcare professionals for care in various indications, including concierge care, men's sexual health, dermatology, and others in the United States. . The company is headquartered in New York, New York.